Literature DB >> 15150677

Angiogenic factors in serum of patients with testicular germ cell tumours.

Simone Ferrero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150677     DOI: 10.1007/s00240-004-0433-7

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


× No keyword cloud information.
  6 in total

1.  Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.

Authors:  R Dittadi; S Meo; F Fabris; G Gasparini; D Contri; M Medici; M Gion
Journal:  Int J Biol Markers       Date:  2001 Apr-Jun       Impact factor: 2.659

2.  Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.

Authors:  K Werther; I J Christensen; H J Nielsen
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

3.  Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular germ cell tumors.

Authors:  Wassilios Bentas; Wolf-Dietrich Beecken; Wolfgang Glienke; Jochen Binder; Horst Schuldes
Journal:  Urol Res       Date:  2002-11-21

4.  Involvement of platelets in tumour angiogenesis?

Authors:  H M Pinedo; H M Verheul; R J D'Amato; J Folkman
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

Review 5.  A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

Authors:  E Hormbrey; P Gillespie; K Turner; C Han; A Roberts; D McGrouther; A L Harris
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

Authors:  R E Banks; M A Forbes; S E Kinsey; A Stanley; E Ingham; C Walters; P J Selby
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.